Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Currently, there is very little research to identify ways to decrease blood loss during D&E
(dilation and evacuation) procedures. The objective is to determine whether routine use of
intravenous oxytocin will improve bleeding outcomes at the time of D&E at 18-24-weeks
gestation. To evaluate the hypothesis, investigators will perform a randomized,
double-blinded, placebo-controlled trial. The patient will be followed until discharged from
the postoperative care unit during which time patient satisfaction, pain score and
postoperative bleeding will be assessed.
Phase:
N/A
Details
Lead Sponsor:
University of Hawaii
Collaborators:
Society of Family Planning University of Washington